SOTERA HEALTH CO (SHC) Stock Fundamental Analysis

NASDAQ:SHC • US83601L1026

17.49 USD
+0.09 (+0.52%)
At close: Feb 20, 2026
17.49 USD
0 (0%)
After Hours: 2/20/2026, 8:04:54 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

SHC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. SHC scores excellent on profitability, but there are concerns on its financial health. SHC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year SHC was profitable.
  • In the past year SHC had a positive cash flow from operations.
  • In multiple years SHC reported negative net income over the last 5 years.
  • Of the past 5 years SHC 4 years had a positive operating cash flow.
SHC Yearly Net Income VS EBIT VS OCF VS FCFSHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

  • SHC has a better Return On Assets (1.74%) than 70.69% of its industry peers.
  • Looking at the Return On Equity, with a value of 10.07%, SHC belongs to the top of the industry, outperforming 81.03% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 9.23%, SHC belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for SHC is below the industry average of 12.04%.
  • The last Return On Invested Capital (9.23%) for SHC is above the 3 year average (8.04%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.74%
ROE 10.07%
ROIC 9.23%
ROA(3y)-1.47%
ROA(5y)-0.34%
ROE(3y)-14.75%
ROE(5y)-6.62%
ROIC(3y)8.04%
ROIC(5y)7.61%
SHC Yearly ROA, ROE, ROICSHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • SHC has a better Profit Margin (4.82%) than 72.41% of its industry peers.
  • SHC's Profit Margin has declined in the last couple of years.
  • SHC's Operating Margin of 29.89% is amongst the best of the industry. SHC outperforms 100.00% of its industry peers.
  • SHC's Operating Margin has improved in the last couple of years.
  • The Gross Margin of SHC (55.98%) is better than 70.69% of its industry peers.
  • In the last couple of years the Gross Margin of SHC has grown nicely.
Industry RankSector Rank
OM 29.89%
PM (TTM) 4.82%
GM 55.98%
OM growth 3Y-0.64%
OM growth 5Y2.13%
PM growth 3Y-31.23%
PM growth 5YN/A
GM growth 3Y-0.57%
GM growth 5Y1.5%
SHC Yearly Profit, Operating, Gross MarginsSHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SHC is destroying value.
  • The number of shares outstanding for SHC has been increased compared to 1 year ago.
  • SHC has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SHC has a worse debt to assets ratio.
SHC Yearly Shares OutstandingSHC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
SHC Yearly Total Debt VS Total AssetsSHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 1.72, we must say that SHC is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.72, SHC is in line with its industry, outperforming 58.62% of the companies in the same industry.
  • SHC has a debt to FCF ratio of 25.87. This is a negative value and a sign of low solvency as SHC would need 25.87 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 25.87, SHC is in line with its industry, outperforming 56.90% of the companies in the same industry.
  • A Debt/Equity ratio of 4.04 is on the high side and indicates that SHC has dependencies on debt financing.
  • SHC's Debt to Equity ratio of 4.04 is on the low side compared to the rest of the industry. SHC is outperformed by 91.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.04
Debt/FCF 25.87
Altman-Z 1.72
ROIC/WACC0.83
WACC11.08%
SHC Yearly LT Debt VS Equity VS FCFSHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

  • SHC has a Current Ratio of 2.38. This indicates that SHC is financially healthy and has no problem in meeting its short term obligations.
  • SHC's Current ratio of 2.38 is in line compared to the rest of the industry. SHC outperforms 46.55% of its industry peers.
  • A Quick Ratio of 2.16 indicates that SHC has no problem at all paying its short term obligations.
  • With a Quick ratio value of 2.16, SHC perfoms like the industry average, outperforming 48.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 2.16
SHC Yearly Current Assets VS Current LiabilitesSHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 8.00% over the past year.
  • Measured over the past years, SHC shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.34% on average per year.
  • SHC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.95%.
  • The Revenue has been growing slightly by 7.17% on average over the past years.
EPS 1Y (TTM)8%
EPS 3Y-7.34%
EPS 5YN/A
EPS Q2Q%52.94%
Revenue 1Y (TTM)-15.95%
Revenue growth 3Y5.71%
Revenue growth 5Y7.17%
Sales Q2Q%9.05%

3.2 Future

  • Based on estimates for the next years, SHC will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.65% on average per year.
  • Based on estimates for the next years, SHC will show a small growth in Revenue. The Revenue will grow by 6.85% on average per year.
EPS Next Y20.93%
EPS Next 2Y16.36%
EPS Next 3Y14.51%
EPS Next 5Y15.65%
Revenue Next Year5.31%
Revenue Next 2Y5.6%
Revenue Next 3Y5.78%
Revenue Next 5Y6.85%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SHC Yearly Revenue VS EstimatesSHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
SHC Yearly EPS VS EstimatesSHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • SHC is valuated rather expensively with a Price/Earnings ratio of 21.59.
  • Based on the Price/Earnings ratio, SHC is valued cheaply inside the industry as 81.03% of the companies are valued more expensively.
  • SHC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.99.
  • Based on the Price/Forward Earnings ratio of 18.45, the valuation of SHC can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SHC indicates a rather cheap valuation: SHC is cheaper than 82.76% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of SHC to the average of the S&P500 Index (28.06), we can say SHC is valued slightly cheaper.
Industry RankSector Rank
PE 21.59
Fwd PE 18.45
SHC Price Earnings VS Forward Price EarningsSHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SHC indicates a rather cheap valuation: SHC is cheaper than 87.93% of the companies listed in the same industry.
  • SHC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SHC is cheaper than 60.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF 57.36
EV/EBITDA 14.1
SHC Per share dataSHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • SHC has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as SHC's earnings are expected to grow with 14.51% in the coming years.
PEG (NY)1.03
PEG (5Y)N/A
EPS Next 2Y16.36%
EPS Next 3Y14.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for SHC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SOTERA HEALTH CO

NASDAQ:SHC (2/20/2026, 8:04:54 PM)

After market: 17.49 0 (0%)

17.49

+0.09 (+0.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-04
Earnings (Next)02-24
Inst Owners58.12%
Inst Owner Change10.15%
Ins Owners2.34%
Ins Owner Change-14.04%
Market Cap4.97B
Revenue(TTM)1.15B
Net Income(TTM)55.42M
Analysts84
Price Target20.85 (19.21%)
Short Float %3.02%
Short Ratio3.34
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.17%
Min EPS beat(2)14.56%
Max EPS beat(2)17.78%
EPS beat(4)4
Avg EPS beat(4)12.29%
Min EPS beat(4)3.1%
Max EPS beat(4)17.78%
EPS beat(8)6
Avg EPS beat(8)7.28%
EPS beat(12)9
Avg EPS beat(12)7.47%
EPS beat(16)13
Avg EPS beat(16)7.3%
Revenue beat(2)2
Avg Revenue beat(2)3.57%
Min Revenue beat(2)1.52%
Max Revenue beat(2)5.63%
Revenue beat(4)3
Avg Revenue beat(4)2.11%
Min Revenue beat(4)-1.22%
Max Revenue beat(4)5.63%
Revenue beat(8)6
Avg Revenue beat(8)0.06%
Revenue beat(12)7
Avg Revenue beat(12)-0.33%
Revenue beat(16)10
Avg Revenue beat(16)0.07%
PT rev (1m)7.97%
PT rev (3m)17.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.62%
EPS NY rev (1m)0.29%
EPS NY rev (3m)6.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.17%
Valuation
Industry RankSector Rank
PE 21.59
Fwd PE 18.45
P/S 4.32
P/FCF 57.36
P/OCF 20.72
P/B 9.03
P/tB N/A
EV/EBITDA 14.1
EPS(TTM)0.81
EY4.63%
EPS(NY)0.95
Fwd EY5.42%
FCF(TTM)0.3
FCFY1.74%
OCF(TTM)0.84
OCFY4.83%
SpS4.05
BVpS1.94
TBVpS-2.93
PEG (NY)1.03
PEG (5Y)N/A
Graham Number5.94
Profitability
Industry RankSector Rank
ROA 1.74%
ROE 10.07%
ROCE 11.68%
ROIC 9.23%
ROICexc 10.27%
ROICexgc 21.53%
OM 29.89%
PM (TTM) 4.82%
GM 55.98%
FCFM 7.53%
ROA(3y)-1.47%
ROA(5y)-0.34%
ROE(3y)-14.75%
ROE(5y)-6.62%
ROIC(3y)8.04%
ROIC(5y)7.61%
ROICexc(3y)9.2%
ROICexc(5y)8.42%
ROICexgc(3y)32.15%
ROICexgc(5y)28.54%
ROCE(3y)10.18%
ROCE(5y)9.64%
ROICexgc growth 3Y-8.13%
ROICexgc growth 5Y-2.77%
ROICexc growth 3Y3.93%
ROICexc growth 5Y7.64%
OM growth 3Y-0.64%
OM growth 5Y2.13%
PM growth 3Y-31.23%
PM growth 5YN/A
GM growth 3Y-0.57%
GM growth 5Y1.5%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 4.04
Debt/FCF 25.87
Debt/EBITDA 4.55
Cap/Depr 106.02%
Cap/Sales 13.32%
Interest Coverage 2.06
Cash Conversion 49.11%
Profit Quality 156.3%
Current Ratio 2.38
Quick Ratio 2.16
Altman-Z 1.72
F-Score5
WACC11.08%
ROIC/WACC0.83
Cap/Depr(3y)123.61%
Cap/Depr(5y)95.16%
Cap/Sales(3y)18.31%
Cap/Sales(5y)14.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8%
EPS 3Y-7.34%
EPS 5YN/A
EPS Q2Q%52.94%
EPS Next Y20.93%
EPS Next 2Y16.36%
EPS Next 3Y14.51%
EPS Next 5Y15.65%
Revenue 1Y (TTM)-15.95%
Revenue growth 3Y5.71%
Revenue growth 5Y7.17%
Sales Q2Q%9.05%
Revenue Next Year5.31%
Revenue Next 2Y5.6%
Revenue Next 3Y5.78%
Revenue Next 5Y6.85%
EBIT growth 1Y-6.5%
EBIT growth 3Y5.04%
EBIT growth 5Y9.46%
EBIT Next Year29.61%
EBIT Next 3Y13.68%
EBIT Next 5Y12.3%
FCF growth 1Y122.75%
FCF growth 3Y-36.88%
FCF growth 5Y-13.23%
OCF growth 1Y250.92%
OCF growth 3Y-7.31%
OCF growth 5Y8.51%

SOTERA HEALTH CO / SHC FAQ

What is the fundamental rating for SHC stock?

ChartMill assigns a fundamental rating of 5 / 10 to SHC.


What is the valuation status of SOTERA HEALTH CO (SHC) stock?

ChartMill assigns a valuation rating of 6 / 10 to SOTERA HEALTH CO (SHC). This can be considered as Fairly Valued.


What is the profitability of SHC stock?

SOTERA HEALTH CO (SHC) has a profitability rating of 7 / 10.


How financially healthy is SOTERA HEALTH CO?

The financial health rating of SOTERA HEALTH CO (SHC) is 3 / 10.